- AVF Academy
- Related Posts
Related
Posts related to: COVID-19 Session: Anticoagulation, VTE Burden and Resources
- Mar 2, 2026This late breaking trials session previewed new devices and multicenter data across venous disease. Presenters shared early r... more details
- Mar 1, 2026A morning of industry sponsored talks and cases for trainees, held before the hands on stations. Two speakers argue that trea... more details
- Mar 1, 2026Four advanced practice providers presented their own data in what the society marked as the first abstract session of its kin... more details
- Mar 1, 2026Seven papers, covering antithrombotic therapy after iliac vein stenting, frailty and exercise in venous leg ulcer healing, GL... more details
- Mar 1, 2026This joint general session brought together the American Venous Forum, European Venous Forum, Society of Interventional Radio... more details
- Feb 28, 2026Four clinicians walk advanced practice providers through pulmonary embolism from the first presentation to long term follow-u... more details
- Feb 28, 2026An interactive case session for fellows, residents and medical students working through superficial, deep, pelvic, wound and... more details
- Feb 28, 2026Four speakers look past the vein itself at the things that shape outcomes in clinic. A pelvic physical therapist explains wha... more details
- Nov 12, 2025This Penumbra sponsored webinar presented full results from the STORM-PE randomized trial and the STRIKE-PE registry alongsid... more details
- Nov 12, 2025This joint EAVLA and AVF phlebology webinar reviewed four JVS Venous and Lymphatic studies. A 346 patient cohort found foam s... more details
- Oct 21, 2025AVF names Brajesh Lal, MD its first Chief Scientific Advisor to guide research strategy and grant development. The issue reca... more details
- Aug 5, 2025This industry-contributed issue reviews new venous device evidence: an updated Living Network Meta-Analysis finds Varithena p... more details
- Aug 5, 2025This industry-contributed issue profiles four venous care products. Methapharm describes its Asclera and ScleroSafe sclerothe... more details
- Jun 16, 2025This issue tackles three underrecognized areas of pelvic venous disease. A retrospective institutional review finds pelvic co... more details
- Feb 20, 2025A novel technology session previewed a wave of emerging venous studies, from an AI-guided compression ultrasound validated ag... more details
- Feb 20, 2025An invited talk reviewed why anticoagulant development is moving past factor Xa and thrombin toward upstream factor XI inhibi... more details

